These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 804391)

  • 1. Light chain proteinuria and cellular mediated immunity in rifampin treated patients with tuberculosis.
    Graber CD; Patrick CC; Galphin RL
    Chest; 1975 Apr; 67(4):408-10. PubMed ID: 804391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell mediated and humoral immunity and light-chain proteinuria in rifampicin-treated tuberculous patients.
    Galal SH; Khalil SH; el Husseiny W; Brock J
    Allerg Immunol (Leipz); 1988; 34(4):249-54. PubMed ID: 3147590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-chain proteinuria and reversible renal failure in rifampin-treated patients with tuberculosis.
    Kumar S; Mehta JA; Trivedi HL
    Chest; 1976 Oct; 70(4):564-5. PubMed ID: 824103
    [No Abstract]   [Full Text] [Related]  

  • 4. Light chain proteinuria and humoral immunoincompetence in tuberculous patients treated with rifampin.
    Graber CD; Jebaily J; Galphin RL; Doering E
    Am Rev Respir Dis; 1973 May; 107(5):713-7. PubMed ID: 4695622
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin induced light chain proteinuria and renal failure.
    Winter RJ; Banks RA; Collins CM; Hoffbrand BI
    Thorax; 1984 Dec; 39(12):952-3. PubMed ID: 6440306
    [No Abstract]   [Full Text] [Related]  

  • 6. Insidious rifampin-associated renal failure with light-chain proteinuria.
    Warrington RJ; Hogg GR; Paraskevas F; Tse KS
    Arch Intern Med; 1977 Jul; 137(7):927-30. PubMed ID: 406868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR.
    Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J
    Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin and cell-mediated immune responses in tuberculosis.
    Goldstein RA; Ang UH; Foellmer JW; Janicki BW
    Am Rev Respir Dis; 1976 Feb; 113(2):197-202. PubMed ID: 1247234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study concerning the early immunosuppressive effects of rifampin in man.
    Litwin A; Brooks SM; Claes F
    Chest; 1974 May; 65(5):548-51. PubMed ID: 4856954
    [No Abstract]   [Full Text] [Related]  

  • 10. No effect of rifampicin upon urinary light chain excretion.
    Stanford CF; Bell A; Nesbitt S
    Eur J Respir Dis; 1987 Aug; 71(2):93-5. PubMed ID: 3113995
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulin K light chain deficiency: A rare, but probably underestimated, humoral immune defect.
    Sala P; Colatutto A; Fabbro D; Mariuzzi L; Marzinotto S; Toffoletto B; Perosa AR; Damante G
    Eur J Med Genet; 2016 Apr; 59(4):219-22. PubMed ID: 26853951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled double-blind study of the effect of rifampin on humoral and cellular immune responses in patients with pulmonary tuberculosis and in tuberculosis contacts.
    Humber DP; Nsanzumuhire H; Aluoch JA; Webster AD; Aber VR; Mitchison DA; Girling DJ; Nunn AJ
    Am Rev Respir Dis; 1980 Sep; 122(3):425-36. PubMed ID: 7416618
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
    Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A
    Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampin-induced nephrotic syndrome and acute interstitial nephritis.
    Neugarten J; Gallo GR; Baldwin DS
    Am J Nephrol; 1983; 3(1):38-42. PubMed ID: 6837651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the effect of rifampicin on antituberculosis immunity].
    Chernushenko EF; Shiniberov VA
    Probl Tuberk; 1983 Feb; (2):47-51. PubMed ID: 6601802
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo cellular immunity in anergic miliary tuberculosis.
    Waxman J; Lockshin M
    Am Rev Respir Dis; 1973 Apr; 107(4):661-4. PubMed ID: 4697674
    [No Abstract]   [Full Text] [Related]  

  • 18. Ratio of urinary free immunoglobulin light chain kappa to lambda in the diagnosis of Bence Jones proteinuria.
    Nakano T; Nagata A; Takahashi H
    Clin Chem Lab Med; 2004 Apr; 42(4):429-34. PubMed ID: 15147154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ratio of light kappa to lambda chains in monoclonal non-reticuloma protein].
    Snigurowicz J
    Pol Tyg Lek; 1975 May; 30(19):789-91. PubMed ID: 49046
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Moore TL
    Scand J Immunol; 2007 Jan; 65(1):76-83. PubMed ID: 17212770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.